BACKGROUND: @entity779 is commonly associated with @entity925 , but there is paucity of studies on the frequency, severity, and basis of muscle involvement. The aim of this study was to document the clinical, electromyographic, and histological changes in @entity779 -associated @entity121 . MATERIALS AND METHODS: Seropositive @entity779 @entity1 admitted to the neurology ward during 2010 were enrolled in this study. Detailed medical history, including bleeding @entity1668 and @entity7555 , were noted. Muscle power on a 0-5 scale, muscle tone, reflex, sensations and coordination were tested. Blood counts, hemoglobin, and serum chemistry, including @entity908 kinase (CK) evaluations, were carried out. Concentric needle electromyography (EMG) and muscle biopsy were performed when clinical conditions were suitable. RESULTS: The study cohort comprised 39 @entity1 with @entity779 , with a median age of 28 years. Of these, 31 @entity1 showed evidence of muscle involvement-16 with clinical and 15 with subclinical muscle involvement. Eight of these @entity1 had severe @entity425 and five had @entity427 . @entity882 was present in 26 patients, elevated serum @entity1011 in three @entity1 and @entity409 in 31 @entity1 . The median CK level was 837 (range 194-3,832) U/L. The EMG revealed polyphasic normal to short duration motor unit potentials, but spontaneous activity was absent. Muscle biopsy in three @entity1 revealed @entity548 with occasional @entity39 and myophagocytosis. There was no @entity1333 , but subtle inflammatory changes were present in one @entity1 . The severity of @entity425 correlated with the platelet count and CK level. All @entity1 improved by 15 days of treatment initiation. CONCLUSION: @entity779 commonly results in benign and self-limiting transient @entity121 .

XXXX : clinical, electromyography and histopathological changes.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1668 :: ('MESH:D004198', 'Disease') :: ['diathesis'] @entity882 :: ('MESH:D013921', 'Disease') :: ['Thrombocytopenia'] @entity548 :: ('MESH:D006470', 'Disease') :: ['interstitial hemorrhage'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis'] @entity908 :: ('MESH:D003401', 'Chemical') :: ['creatine'] @entity1333 :: ('MESH:D014657', 'Disease') :: ['vasculitis'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver dysfunction'] @entity425 :: ('MESH:D018908', 'Disease') :: ['muscle weakness', 'weakness'] @entity7555 :: ('MESH:D016878', 'Disease') :: ['organomegaly'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity779 :: ('MESH:D003715', 'Disease') :: ['Dengue', 'dengue'] @entity925 :: ('MESH:D063806', 'Disease') :: ['myalgia'] @entity121 :: ('MESH:D009135', 'Disease') :: ['muscle dysfunction'] @entity427 :: ('MESH:D012021', 'Disease') :: ['hyporeflexia']
@entity121 :: (MESH:D009135,Disease) :: ['Dengue-associated transient muscle dysfunction']
